China Drugs for Osteoarthritis Pain Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Drugs for Osteoarthritis Pain Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Drugs for Osteoarthritis Pain Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Drugs for Osteoarthritis Pain Overall Market Size
2.1 China Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027
2.2 China Drugs for Osteoarthritis Pain Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Osteoarthritis Pain Players in China Market
3.2 Top China Drugs for Osteoarthritis Pain Companies Ranked by Revenue
3.3 China Drugs for Osteoarthritis Pain Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Osteoarthritis Pain Companies in China Market, by Revenue in 2020
3.5 Companies Drugs for Osteoarthritis Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Players in China Market
3.6.1 List of Tier 1 Drugs for Osteoarthritis Pain Companies in China
3.6.2 List of Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Drugs for Osteoarthritis Pain Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - China Drugs for Osteoarthritis Pain Revenue & Forecasts
4.2.1 By Type - China Drugs for Osteoarthritis Pain Revenue, 2016-2021
4.2.2 By Type - China Drugs for Osteoarthritis Pain Revenue, 2022-2027
4.2.3 By Type - China Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - China Drugs for Osteoarthritis Pain Revenue & Forecasts
5.2.1 By Application - China Drugs for Osteoarthritis Pain Revenue, 2016-2021
5.2.2 By Application - China Drugs for Osteoarthritis Pain Revenue, 2022-2027
5.2.3 By Application - China Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
6 Drugs for Osteoarthritis Pain Companies Profiles
6.1 Pfizer
6.1.1 Pfizer Company Details
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
6.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.1.5 Pfizer Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Details
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
6.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.2.5 Johnson & Johnson Recent Developments
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Details
6.3.2 GlaxoSmithKline Business Overview
6.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
6.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.3.5 GlaxoSmithKline Recent Developments
6.4 Bayer
6.4.1 Bayer Company Details
6.4.2 Bayer Business Overview
6.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
6.4.4 Bayer Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.4.5 Bayer Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Company Details
6.5.2 Eli Lilly Business Overview
6.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
6.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.5.5 Eli Lilly Recent Developments
6.6 Novartis
6.6.1 Novartis Company Details
6.6.2 Novartis Business Overview
6.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
6.6.4 Novartis Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.6.5 Novartis Recent Developments
6.7 Sanofi
6.7.1 Sanofi Company Details
6.7.2 Sanofi Business Overview
6.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
6.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.7.5 Sanofi Recent Developments
6.8 Horizon Pharma
6.8.1 Horizon Pharma Company Details
6.8.2 Horizon Pharma Business Overview
6.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
6.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.8.5 Horizon Pharma Recent Developments
6.9 Abbott
6.9.1 Abbott Company Details
6.9.2 Abbott Business Overview
6.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
6.9.4 Abbott Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.9.5 Abbott Recent Developments
6.10 Mylan
6.10.1 Mylan Company Details
6.10.2 Mylan Business Overview
6.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
6.10.4 Mylan Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.10.5 Mylan Recent Developments
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Company Details
6.11.2 Daiichi Sankyo Business Overview
6.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
6.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.11.5 Daiichi Sankyo Recent Developments
6.12 TEVA
6.12.1 TEVA Company Details
6.12.2 TEVA Business Overview
6.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
6.12.4 TEVA Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.12.5 TEVA Recent Developments
6.13 Almatica Pharma
6.13.1 Almatica Pharma Company Details
6.13.2 Almatica Pharma Business Overview
6.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
6.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.13.5 Almatica Pharma Recent Developments
6.14 Astellas Pharma
6.14.1 Astellas Pharma Company Details
6.14.2 Astellas Pharma Business Overview
6.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
6.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.14.5 Astellas Pharma Recent Developments
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Company Details
6.15.2 Tide Pharmaceutical Business Overview
6.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
6.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.15.5 Tide Pharmaceutical Recent Developments
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Company Details
6.16.2 Iroko Pharmaceuticals Business Overview
6.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
6.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.16.5 Iroko Pharmaceuticals Recent Developments
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Company Details
6.17.2 Hengrui Pharmaceutical Business Overview
6.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
6.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.17.5 Hengrui Pharmaceutical Recent Developments
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Company Details
6.18.2 Abiogen Pharma Business Overview
6.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
6.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021)
6.18.5 Abiogen Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Drugs for Osteoarthritis Pain Market Opportunities & Trends in China Market
Table 2. Drugs for Osteoarthritis Pain Market Drivers in China Market
Table 3. Drugs for Osteoarthritis Pain Market Restraints in China Market
Table 4. Key Players of Drugs for Osteoarthritis Pain in China Market
Table 5. Top Drugs for Osteoarthritis Pain Players in China Market, Ranking by Revenue (2019)
Table 6. China Drugs for Osteoarthritis Pain Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Drugs for Osteoarthritis Pain Revenue Share by Companies, 2016-2021
Table 8. Companies Drugs for Osteoarthritis Pain Product Type
Table 9. List of Tier 1 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 17. Pfizer Company Details
Table 18. Pfizer Business Overview
Table 19. Pfizer Drugs for Osteoarthritis Pain Product
Table 20. Pfizer Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Pfizer Recent Developments
Table 22. Johnson & Johnson Company Details
Table 23. Johnson & Johnson Business Overview
Table 24. Johnson & Johnson Drugs for Osteoarthritis Pain Product
Table 25. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Johnson & Johnson Recent Developments
Table 27. GlaxoSmithKline Company Details
Table 28. GlaxoSmithKline Business Overview
Table 29. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
Table 30. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 31. GlaxoSmithKline Recent Developments
Table 32. Bayer Company Details
Table 33. Bayer Business Overview
Table 34. Bayer Drugs for Osteoarthritis Pain Product
Table 35. Bayer Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Bayer Recent Developments
Table 37. Eli Lilly Company Details
Table 38. Eli Lilly Business Overview
Table 39. Eli Lilly Drugs for Osteoarthritis Pain Product
Table 40. Eli Lilly Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Eli Lilly Recent Developments
Table 42. Novartis Company Details
Table 43. Novartis Business Overview
Table 44. Novartis Drugs for Osteoarthritis Pain Product
Table 45. Novartis Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Novartis Recent Developments
Table 47. Sanofi Company Details
Table 48. Sanofi Business Overview
Table 49. Sanofi Drugs for Osteoarthritis Pain Product
Table 50. Sanofi Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Sanofi Recent Developments
Table 52. Horizon Pharma Company Details
Table 53. Horizon Pharma Business Overview
Table 54. Horizon Pharma Drugs for Osteoarthritis Pain Product
Table 55. Horizon Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Horizon Pharma Recent Developments
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott Drugs for Osteoarthritis Pain Product
Table 60. Abbott Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Abbott Recent Developments
Table 62. Mylan Company Details
Table 63. Mylan Business Overview
Table 64. Mylan Drugs for Osteoarthritis Pain Product
Table 65. Mylan Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Mylan Recent Developments
Table 67. Daiichi Sankyo Company Details
Table 68. Daiichi Sankyo Business Overview
Table 69. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
Table 70. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Daiichi Sankyo Recent Developments
Table 72. TEVA Company Details
Table 73. TEVA Business Overview
Table 74. TEVA Drugs for Osteoarthritis Pain Product
Table 75. TEVA Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 76. TEVA Recent Developments
Table 77. Almatica Pharma Company Details
Table 78. Almatica Pharma Business Overview
Table 79. Almatica Pharma Drugs for Osteoarthritis Pain Product
Table 80. Almatica Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 81. Almatica Pharma Recent Developments
Table 82. Astellas Pharma Company Details
Table 83. Astellas Pharma Business Overview
Table 84. Astellas Pharma Drugs for Osteoarthritis Pain Product
Table 85. Astellas Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Astellas Pharma Recent Developments
Table 87. Tide Pharmaceutical Business Overview
Table 88. Tide Pharmaceutical Company Details
Table 89. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 90. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 91. Tide Pharmaceutical Recent Developments
Table 92. Iroko Pharmaceuticals Company Details
Table 93. Iroko Pharmaceuticals Business Overview
Table 94. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
Table 95. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 96. Iroko Pharmaceuticals Recent Developments
Table 97. Hengrui Pharmaceutical Company Details
Table 98. Hengrui Pharmaceutical Business Overview
Table 99. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
Table 100. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 101. Hengrui Pharmaceutical Recent Developments
Table 102. Abiogen Pharma Company Details
Table 103. Abiogen Pharma Business Overview
Table 104. Abiogen Pharma Drugs for Osteoarthritis Pain Product
Table 105. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in China Market (2016-2021) & (US$ Million)
Table 106. Abiogen Pharma Recent Developments
List of FiguresFigure 1. Drugs for Osteoarthritis Pain Segment by Type
Figure 2. Drugs for Osteoarthritis Pain Segment by Application
Figure 3. China Drugs for Osteoarthritis Pain Market Overview: 2020
Figure 4. China Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Drugs for Osteoarthritis Pain Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2020
Figure 7. By Type - China Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 8. By Application - China Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 9. Pfizer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Bayer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Eli Lilly Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Novartis Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Sanofi Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Horizon Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Abbott Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Mylan Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. TEVA Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Almatica Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Astellas Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)